{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:08:11Z","timestamp":1788782891069,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.schres.2026.07.004","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:20:38Z","timestamp":1783398038000},"page":"67-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Initiation patterns of long-acting injectable antipsychotics in a claims-based proxy cohort approximating first-episode schizophrenia: A longitudinal descriptive study using a Japanese claims database"],"prefix":"10.1016","volume":"296","author":[{"given":"Ryosuke","family":"Miyagawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2026.07.004_bb0005","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.schres.2021.03.013","article-title":"Employment and relationship outcomes in first-episode psychosis: a systematic review and meta-analysis of longitudinal studies","volume":"231","author":"Ajnakina","year":"2021","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.07.004_bb0010","first-page":"95","article-title":"Covid-19 pandemic impact on mental health of vulnerable populations","volume":"91","author":"Amerio","year":"2020","journal-title":"Acta Biomed"},{"key":"10.1016\/j.schres.2026.07.004_bb0015","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/pds.1230","article-title":"Methods for evaluation of medication adherence and persistence using automated databases","volume":"15","author":"Andrade","year":"2006","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.schres.2026.07.004_bb0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1192\/S0007125000297663","article-title":"Early intervention in psychosis: the critical period hypothesis","volume":"172","author":"Birchwood","year":"1998","journal-title":"Br. J. Psychiatry Suppl."},{"key":"10.1016\/j.schres.2026.07.004_bb0025","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1751-7893.2009.00148.x","article-title":"Review of the operational definition for first-episode psychosis","volume":"3","author":"Breitborde","year":"2009","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.004_bb0030","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1034\/j.1600-0447.2002.02437.x","article-title":"Medication adherence of individuals with a first episode of psychosis","volume":"106","author":"Coldham","year":"2002","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2026.07.004_bb0035","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00127-002-0582-3","article-title":"Young cases of schizophrenia identified in a national inpatient register: are the diagnoses valid?","volume":"37","author":"Dalman","year":"2002","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.schres.2026.07.004_bb0040","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/wps.20446","article-title":"Improving outcomes of first-episode psychosis: an overview","volume":"16","author":"Fusar-Poli","year":"2017","journal-title":"World Psychiatry"},{"key":"10.1016\/j.schres.2026.07.004_bb0045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jpsychires.2020.05.012","article-title":"The 12-year trend report of antipsychotic usage in a nationwide claims database derived from four million people in Japan","volume":"127","author":"Hata","year":"2020","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2026.07.004_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/npr2.12497","article-title":"Guideline for pharmacological treatment of schizophrenia 2022","volume":"45","author":"Japanese Society of Neuropsychopharmacology","year":"2025","journal-title":"Neuropsychopharmacol. Rep."},{"key":"10.1016\/j.schres.2026.07.004_bb0065","doi-asserted-by":"crossref","first-page":"345","DOI":"10.31887\/DCNS.2010.12.3\/jkane","article-title":"Pharmacologic treatment of schizophrenia","volume":"12","author":"Kane","year":"2010","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.schres.2026.07.004_bb0070","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/wps.20060","article-title":"Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies","volume":"12","author":"Kane","year":"2013","journal-title":"World Psychiatry"},{"key":"10.1016\/j.schres.2026.07.004_bb0080","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/jamapsychiatry.2020.2076","article-title":"Effect of long-acting injectable antipsychotics vs usual care on time to first hospitalization in early-phase schizophrenia: a randomized clinical trial","volume":"77","author":"Kane","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2026.07.004_bb0085","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/YIC.0000000000000452","article-title":"Early versus late administration of long-acting injectable antipsychotic agents among patients with newly diagnosed schizophrenia: an analysis of a commercial claims database","volume":"38","author":"Kane","year":"2023","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2026.07.004_bb0090","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.22m14544","article-title":"Treatment journey from diagnosis to the successful implementation of a long-acting injectable antipsychotic agent in young adults with schizophrenia","volume":"84","author":"Kane","year":"2023","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.004_bb0100","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2188\/jea.JE20090066","article-title":"Development of a database of health insurance claims: standardization of disease classifications and anonymous record linkage","volume":"20","author":"Kimura","year":"2010","journal-title":"J. Epidemiol."},{"key":"10.1016\/j.schres.2026.07.004_bb0105","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/schbul\/sbs150","article-title":"Long-acting injectable versus oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials","volume":"40","author":"Kishimoto","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.07.004_bb0110","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/070674371506000805","article-title":"Validation of a population-based algorithm to detect chronic psychotic illness","volume":"60","author":"Kurdyak","year":"2015","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.schres.2026.07.004_bb0115","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/ije\/dyu149","article-title":"Good practices for quantitative bias analysis","volume":"43","author":"Lash","year":"2014","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.schres.2026.07.004_bb0125","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0006-3223(01)01303-8","article-title":"The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches","volume":"50","author":"Lieberman","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.004_bb0130","first-page":"69","article-title":"Accuracy of diagnoses of schizophrenia in Medicaid claims","volume":"43","author":"Lurie","year":"1992","journal-title":"Hosp. Community Psychiatry"},{"key":"10.1016\/j.schres.2026.07.004_bb0135","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2377-13-16","article-title":"Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance","volume":"13","author":"Marrie","year":"2013","journal-title":"BMC Neurol."},{"key":"10.1016\/j.schres.2026.07.004_bb0140","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.5694\/j.1326-5377.2007.tb01327.x","article-title":"Early intervention in psychotic disorders: detection and treatment of the first episode and the critical early stages","volume":"187","author":"McGorry","year":"2007","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.schres.2026.07.004_bb0145","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-2-13","article-title":"A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology","volume":"2","author":"McGrath","year":"2004","journal-title":"BMC Med."},{"key":"10.1016\/j.schres.2026.07.004_bb0150","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/jgf2.422","article-title":"Data resource profile: JMDC claims database sourced from health insurance societies","volume":"22","author":"Nagai","year":"2021","journal-title":"J. Gen. Fam. Med."},{"key":"10.1016\/j.schres.2026.07.004_bb0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1524-4733.2006.00139.x","article-title":"A checklist for medication compliance and persistence studies using retrospective databases","volume":"10","author":"Peterson","year":"2007","journal-title":"Value Health"},{"key":"10.1016\/j.schres.2026.07.004_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17101700","article-title":"Do atypical antipsychotics have antisuicidal effects? A hypothesis-generating overview","volume":"17","author":"Pompili","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.schres.2026.07.004_bb0195","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med. Care"},{"key":"10.1016\/j.schres.2026.07.004_bb0200","series-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2023"},{"key":"10.1016\/j.schres.2026.07.004_bb0205","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/MLR.0b013e31829b1d2a","article-title":"Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases","volume":"51","author":"Raebel","year":"2013","journal-title":"Med. Care"},{"key":"10.1016\/j.schres.2026.07.004_bb0210","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating medication effects outside of clinical trials: new-user designs","volume":"158","author":"Ray","year":"2003","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.schres.2026.07.004_bb0215","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archpsyc.56.3.241","article-title":"Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder","volume":"56","author":"Robinson","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.004_bb0220","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1007\/s12325-023-02455-8","article-title":"Patient and healthcare professional preferences for characteristics of long-acting injectable antipsychotic agents for the treatment of schizophrenia","volume":"40","author":"Robinson","year":"2023","journal-title":"Adv. Ther."},{"key":"10.1016\/j.schres.2026.07.004_bb0225","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.22m14604","article-title":"Predictors for initiation of atypical long-acting injectable antipsychotic agents in a commercial claims cohort of individuals with early-phase schizophrenia","volume":"84","author":"Rubio","year":"2023","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.004_bb0235","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jclinepi.2004.10.012","article-title":"A review of uses of health care utilization databases for epidemiologic research on therapeutics","volume":"58","author":"Schneeweiss","year":"2005","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.schres.2026.07.004_bb0240","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0895-4356(96)00268-5","article-title":"The assessment of refill compliance using pharmacy records: methods, validity, and applications","volume":"50","author":"Steiner","year":"1997","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.schres.2026.07.004_bb0245","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1001\/jamapsychiatry.2015.0270","article-title":"Long-acting injectable risperidone for relapse prevention and control of breakthrough symptoms after a recent first episode of schizophrenia: a randomized clinical trial","volume":"72","author":"Subotnik","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2026.07.004_bb0250","doi-asserted-by":"crossref","DOI":"10.1111\/appy.12393","article-title":"Patterns of long-acting injectable antipsychotic use and associated clinical factors in schizophrenia among 15 Asian countries and regions","volume":"12","author":"Tang","year":"2020","journal-title":"Asia Pac. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.004_bb0255","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1176\/appi.ajp.2011.10081224","article-title":"A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia","volume":"168","author":"Tiihonen","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.004_bb0260","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12911-015-0155-5","article-title":"Methods for identifying 30 chronic conditions: application to administrative data","volume":"15","author":"Tonelli","year":"2015","journal-title":"BMC Med. Inform. Decis. Mak."},{"key":"10.1016\/j.schres.2026.07.004_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040296","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"4","author":"von Elm","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.schres.2026.07.004_bb0270","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology, n.d. ATC\/DDD Index: Antipsychotics, ATC Code N05A. WHO Collaborating Centre for Drug Statistics Methodology, Oslo. Accessed 20 May 2026."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426002136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426002136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:18:05Z","timestamp":1788779885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996426002136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":42,"alternative-id":["S0920996426002136"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2026.07.004","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Initiation patterns of long-acting injectable antipsychotics in a claims-based proxy cohort approximating first-episode schizophrenia: A longitudinal descriptive study using a Japanese claims database","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2026.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}